Legend Biotech Ownership | Who Owns Legend Biotech?

Legend Biotech Ownership Summary

Legend Biotech is owned by 55.77% institutional investors, 1.25% insiders, and 42.97% retail investors. Fmr is the largest institutional shareholder, holding 15.75% of LEGN shares. Fidelity OTC is the top mutual fund, with 1.92% of its assets in Legend Biotech shares.

LEGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Legend Biotech	55.77%	1.25%	42.97%
Sector	Healthcare Stocks	245.07%	12.10%	-157.17%
Industry	Biotech Stocks	380.48%	11.73%	-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	29.09M	15.75%	$840.23M
Deerfield management company, l.p. (series c)	8.14M	4.41%	$235.01M
Suvretta capital management	7.07M	3.83%	$204.18M
Hhlr advisors	5.98M	3.24%	$172.83M
Blackrock	5.72M	3.14%	$253.40M
Blackrock funding, inc. /de	4.73M	2.56%	$136.50M
Westfield capital management co lp	4.43M	2.40%	$127.94M
Goldman sachs group	3.66M	1.98%	$105.77M
Point72 asset management	3.08M	1.67%	$88.84M
Kynam capital management, lp	3.00M	1.62%	$86.67M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Hhlr advisors	5.98M	20.77%	$172.83M
Ivyrock asset management (hk)	801.00K	13.08%	$23.13M
Matthews capital management	917.27K	9.08%	$26.49M
Davern capital partners, lp	1.19M	5.87%	$34.41M
Kynam capital management, lp	3.00M	4.79%	$86.67M
Monashee investment management	85.39K	4.14%	$2.47M
Suvretta capital management	7.07M	3.73%	$204.18M
Resolute capital asset partners	260.87K	3.22%	$7.53M
Triata capital	629.91K	3.09%	$18.19M
Johnson & johnson	814.59K	2.95%	$23.53M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	29.09M	0.04%	3.40M
Goldman sachs group	3.66M	0.01%	2.20M
Assenagon asset management	1.92M	0.07%	1.92M
Kynam capital management, lp	3.00M	4.79%	1.42M
Soleus capital management	1.21M	1.20%	1.21M

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-7.51M
Capital world investors	-	-	-2.39M
First beijing investment	-	-	-2.30M
Two sigma investments, lp	163.90K	0.00%	-1.73M
Alliancebernstein	-	-	-1.52M

New Positions

Holder	Shares	% Assets	Change	Value
Assenagon asset management	1.92M	0.07%	1.92M	$55.31M
Soleus capital management	1.21M	1.20%	1.21M	$34.80M
Driehaus capital management	1.16M	0.19%	1.16M	$33.47M
Ghisallo capital management	1.00M	0.57%	1.00M	$28.88M
Ecor1 capital	800.00K	1.12%	800.00K	$23.10M

Sold Out

Holder	Change
Abound wealth management	-4.00
Cva family office	-15.00
Smartleaf asset management	-21.00
Parkside financial bank & trust	-23.00
Vermillion & white wealth management group	-25.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	227	8.61%	103,033,692	7.96%	55	2.09%	124	13.76%	74	39.62%
Mar 31, 2026	119	-44.65%	27,360,336	-68.76%	14	0.16%	63	-40.57%	30	-53.13%
Dec 31, 2025	139	-35.65%	28,301,091	-66.19%	31	0.38%	66	-40.00%	41	-28.07%
Sep 30, 2025	208	-7.56%	83,554,687	-1.27%	90	4.30%	104	-4.59%	57	-32.94%
Jun 30, 2025	224	2.75%	84,632,757	-1.43%	45	2.11%	108	5.88%	85	10.39%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity OTC	3.71M	1.92%	-
Invesco Emerging Markets Equity	2.69M	1.46%	-277.61K
Invesco Developing Markets A	2.69M	1.46%	-
Fidelity Growth Compy Commingled Pl O	2.43M	1.32%	-
Fidelity Select Pharmaceuticals Port	2.51M	1.30%	3.80K
T. Rowe Price US Growth Stock Composite	2.32M	1.26%	-77.22K
T. Rowe Price Growth Stock	2.27M	1.24%	-32.51K
Jupiter Merian Glb Eq AbsRet I USD Acc	2.09M	1.13%	2.09M
Jupiter Merian Glb Eq Abs Rt I USD Acc	2.09M	1.08%	2.09M
Fidelity Select Health Care	2.01M	1.04%	14.32K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 30, 2026	Casey Patrick John	-	Sell	$88.80K
Jun 25, 2026	Huang Ying	Chief Executive Officer	Sell	$82.27K
Mar 25, 2026	Huang Ying	Chief Executive Officer	Sell	$87.14K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	2
2026 Q1	-	1

LEGN Ownership FAQ

Who Owns Legend Biotech?

Legend Biotech shareholders are primarily institutional investors at 55.77%, followed by 1.25% insiders and 42.98% retail investors. The average institutional ownership in Legend Biotech's industry, Biotech Stocks , is 380.48%, which Legend Biotech falls below.

Who owns the most shares of Legend Biotech?

Legend Biotech’s largest shareholders are Fmr (29.09M shares, 15.75%), Deerfield management company, l.p. (series c) (8.14M shares, 4.41%), and Suvretta capital management (7.07M shares, 3.83%). Together, they hold 23.98% of Legend Biotech’s total shares outstanding.

Does Blackrock own Legend Biotech?

Yes, BlackRock owns 3.14% of Legend Biotech, totaling 5.72M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 253.4M$. In the last quarter, BlackRock increased its holdings by 337.25K shares, a 6.26% change.

Who is Legend Biotech’s biggest shareholder by percentage of total assets invested?

Hhlr advisors is Legend Biotech’s biggest shareholder by percentage of total assets invested, with 20.77% of its assets in 5.98M Legend Biotech shares, valued at 172.83M$.

Who is the top mutual fund holder of Legend Biotech shares?

Fidelity OTC is the top mutual fund holder of Legend Biotech shares, with 1.92% of its total shares outstanding invested in 3.71M Legend Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools